综述 |
|
|
|
|
经皮给药纳米载体及靶向系统治疗类风湿关节炎研究进展 * |
胡胜涛1,张二兵1,林也1,张逢1,黄丹1,宋厚盼1,刘斌2,蔡雄1,**() |
1 湖南中医药大学中药粉体与创新药物省部共建国家重点实验室(培育基地) 长沙 410208 2 湖南大学生物学院 长沙 410082 |
|
Research Advances on the Therapy of Rheumatoid Arthritis with the Nanotechnology Based on Transdermal Drug Delivery System |
HU Sheng-tao1,ZHANG Er-bing1,LIN Ye1,ZHANG Feng1,HUANG Dan1,SONG Hou-pan1,LIU Bin2,CAI Xiong1,**() |
1 Institute of Innovation and Applied Research in Chinese Medicine, Hunan University of Chinese Medicine, Changsha 410208, China 2 College of Biology, Hunan University, Changsha 410082, China |
引用本文:
胡胜涛,张二兵,林也,张逢,黄丹,宋厚盼,刘斌,蔡雄. 经皮给药纳米载体及靶向系统治疗类风湿关节炎研究进展 *[J]. 中国生物工程杂志, 2021, 41(2/3): 98-106.
HU Sheng-tao,ZHANG Er-bing,LIN Ye,ZHANG Feng,HUANG Dan,SONG Hou-pan,LIU Bin,CAI Xiong. Research Advances on the Therapy of Rheumatoid Arthritis with the Nanotechnology Based on Transdermal Drug Delivery System. China Biotechnology, 2021, 41(2/3): 98-106.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.2011013
或
https://manu60.magtech.com.cn/biotech/CN/Y2021/V41/I2/3/98
|
[1] |
Smolen J S, Aletaha D, Barton A, et al. Rheumatoid arthritis. Nature Reviews Disease Primers, 2018,4(Suppl 10):60-75.
|
[2] |
Li Z G. A new look at rheumatology in China:Opportunities and challenges. Nature Reviews Rheumatology, 2015,11(5):313-317.
pmid: 25599919
|
[3] |
谢文慧, 张卓莉. 类风湿关节炎治疗目标的研究进展. 中华风湿病学杂志, 2019,23(3):195-198.
|
|
Xie W H, Zhang Z L. Research progress on the therapeutic goals of rheumatoid arthritis. Chinese Journal of Rheumatology, 2019,23(3):195-198.
|
[4] |
Burmester G R, Pope J E. Novel treatment strategies in rheumatoid arthritis. The Lancet, 2017,389(10086):2338-2348.
|
[5] |
Oliveira I M, Gon?alves C, Reis R L, et al. Engineering nanoparticles for targeting rheumatoid arthritis: Past, present, and future trends. Nano Research, 2018. 11(9):4489-4506.
|
[6] |
庞晓晨, 成睿珍, 赵静, 等. 中药透皮给药系统研究进展及其新剂型的应用. 中国新药杂志, 2019,28(3):286-291.
|
|
Pang X C, Cheng R Z, Zhao J, et al. Research progress of transdermal drug delivery system of traditional Chinese medicine and the application of new formulations. Chinese Journal of New Drugs, 2019,28(3):286-291.
|
[7] |
Pirmardvand Chegini S, Varshosaz J, Taymouri S. Recent approaches for targeted drug delivery in rheumatoid arthritis diagnosis and treatment. Artificial Cells, Nanomedicine,and Biotechnology, 2018,46(sup2):502-514.
|
[8] |
邢桂英, 邵林军. 纳米载体在中药制剂经皮给药应用中的研究进展. 华西药学杂志, 2020,35(1):101-105.
|
|
Xing G Y, Shao L J. Recent advance of nanocarriers in transdermal drug delivery of traditional Chinese medicine. West China Journal of Pharmaceutical Sciences, 2020,35(1):101-105.
|
[9] |
Wen Y, Lin W, Mettenbrink E M, et al. Nanoparticle toxicology. Annu Rev Pharmacol Toxicol, 2021,61(1):269-289.
|
[10] |
Khan D, Qindeel M, Ahmed N, et al. Development of novel pH-sensitive nanoparticle-based transdermal patch for management of rheumatoid arthritis. Nanomedicine(London, England), 2020,15(6):603-624.
|
[11] |
Gul R, Ahmed N, Ullah N, et al. Biodegradable ingredient-based emulgel loaded with ketoprofen nanoparticles. AAPS Pharm Sci Tech, 2018,19(4):1869-1881.
|
[12] |
El Menshawe S F, Nafady M M, Aboud H M, et al. Transdermal delivery of fluvastatin sodium via tailored spanlastic nanovesicles: mitigated Freund’s adjuvant-induced rheumatoid arthritis in rats through suppressing p38 MAPK signaling pathway. Drug Delivery, 2019,26(1):1140-1154.
|
[13] |
Fernández-García R, Lalatsa A, Statts L, et al. Transferosomes as nanocarriers for drugs across the skin: Quality by design from lab to industrial scale. Int J Pharm, 2020,573:118817.
doi: 10.1016/j.ijpharm.2019.118817
pmid: 31678520
|
[14] |
Marimuthu M, Bennet D, Kim S. Self-assembled nanoparticles of PLGA-conjugated glucosamine as a sustained transdermal drug delivery vehicle. Polymer Journal, 2013,45(2):202-209.
|
[15] |
Zhang Z, Chen Y, Ding J, et al. Biocompatible 5-aminolevulinic acid/Au nanoparticle-loaded ethosomal vesicles for in vitro transdermal synergistic photodynamic/photothermal therapy of hypertrophic scars. Nanoscale Research Letters, 2017,12(1):622.
pmid: 29247361
|
[16] |
Tang Q, Chen C, Jiang Y, et al. Engineering an adhesive based on photosensitive polymer hydrogels and silver nanoparticles for wound healing. Journal of Materials Chemistry B, 2020,8(26):5756-5764.
pmid: 32519734
|
[17] |
Janakiraman K, Krishnaswami V, Rajendran V, et al. Novel Nano therapeutic materials for the effective treatment of rheumatoid arthritis- recent insights. Materials Today Communications, 2018,17:200-213.
doi: 10.1016/j.mtcomm.2018.09.011
pmid: 32289062
|
[18] |
Wen Z, Lin J, Su J Q, et al. Influences of trehalose-modification of solid lipid nanoparticles on drug loading. European Journal of Lipid Science and Technology, 2017,119(9):1600364(1-10).
|
[19] |
Nirbhavane P, Sharma G, Singh B, et al. Preclinical explorative assessment of celecoxib-based biocompatible lipidic nanocarriers for the management of CFA-induced rheumatoid arthritis in Wistar rats. AAPS Pharm SciTech, 2018,19(7):3187-3198.
|
[20] |
Peng L H, Wei W, Shan Y H, et al. Sustained release of piroxicam from solid lipid nanoparticle as an effective anti-inflammatory therapeutics in vivo. Drug Development and Industrial Pharmacy, 2017,43(1):55-66.
pmid: 27498809
|
[21] |
Bhalekar M R, Madgulkar A R, Desale P S, et al. Formulation of piperine solid lipid nanoparticles (SLN) for treatment of rheumatoid arthritis. Drug Development and Industrial Pharmacy, 2017,43(6)1003-1010.
doi: 10.1080/03639045.2017.1291666
pmid: 28161984
|
[22] |
Kaur A, Goindi S, Katare O P. Formulation, characterisation and in vivo evaluation of lipid-based nanocarrier for topical delivery of diflunisal. Journal of Microencapsulation, 2016,33(5):475-486.
|
[23] |
Singh B, Singh R, Bandyopadhyay S, et al. Optimized nanoemulsifying systems with enhanced bioavailability of carvedilol. Colloids and Surfaces B: Biointerfaces, 2013,101:465-474.
pmid: 23010056
|
[24] |
陈雯烨, 王志高, 鞠兴荣, 等. 纳米乳的研究进展与潜在局限性. 粮食科技与经济, 2020,45(3):79-83.
|
|
Chen W Y, Wang Z G, Ju X R, et al. Research progress and potential limitations of nanoemulsions. Grain Science and Technology and Economy, 2020,45(3):79-83.
|
[25] |
Pathan I, Mangle M, Bairagi S. Design and characterization of nanoemulsion for transdermal delivery of meloxicam. Analytical Chemistry Letters, 2016,6(3):286-295.
|
[26] |
Gokhale J P, Mahajan H S, Surana S J. Quercetin loaded nanoemulsion-based gel for rheumatoid arthritis: In vivo and in vitro studies. Biomedicine & Pharmacotherapy, 2019,112:108622.
|
[27] |
Chen Y, Zhu D P, Xiong X P, et al. Magnesium oil enriched transdermal nanogel of methotrexate for improved arthritic joint mobility, repair, and reduced inflammation. Journal of Microencapsulation, 2020,37(1):77-90.
pmid: 31795796
|
[28] |
Shewaiter M A, Hammady T M, El-Gindy A, et al. Formulation and characterization of leflunomide/diclofenac sodium microemulsion base-gel for the transdermal treatment of inflammatory joint diseases. Journal of Drug Delivery Science and Technology, 2021,61:102110.
|
[29] |
Poonia N, Lather V, Kaur B, et al. Optimization and development of methotrexate and resveratrol-loaded nanoemulsion formulation using box-behnken design for rheumatoid arthritis. ASSAY and Drug Development Technologies, 2020,18(8):356-368.
pmid: 33052698
|
[30] |
Khosa A, Reddi S, Saha R N. Nanostructured lipid carriers for site-specific drug delivery. Biomedicine Pharmacother, 2018,103:598-613.
|
[31] |
Gu Y W, Tang X M, Yang M, et al. Transdermal drug delivery of triptolide-loaded nanostructured lipid carriers: Preparation, pharmacokinetic, and evaluation for rheumatoid arthritis. International Journal of Pharmaceutics, 2019,554:235-244.
pmid: 30423415
|
[32] |
Sadarani B, Majumdar A, Paradkar S, et al. Enhanced skin permeation of methotrexate from penetration enhancer containing vesicles: In vitro optimization and in vivo evaluation. Biomedicine & Pharmacotherapy, 2019,114:108770.
pmid: 30913494
|
[33] |
Yurdasiper A, Ertan G, Heard C M. Enhanced delivery of naproxen to the viable epidermis from an activated poly N-isopropylacrylamide (PNIPAM) nanogel: Skin penetration, modulation of COX-2 expression and rat paw oedema. Nanomedicine: Nanotechnology,Biology and Medicine, 2018,14(7):2051-2059.
|
[34] |
Qindeel M, Khan D, Ahmed N, et al. Surfactant-free, self-assembled nanomicelles-based transdermal hydrogel for safe and targeted delivery of methotrexate against rheumatoid arthritis. ACS Nano, 2020,14(4):4662-4681.
doi: 10.1021/acsnano.0c00364
pmid: 32207921
|
[35] |
Filipowicz A, Wo?owiec S. Solubility and in vitro transdermal diffusion of riboflavin assisted by PAMAM dendrimers. International Journal of Pharmaceutics, 2011,408(1-2):152-156.
|
[36] |
谭玉静, 洪枫, 邵志宇. 细菌纤维素在生物医学材料中的应用. 中国生物工程杂志, 2007,27(4):126-131.
|
|
Tan Y J, Hong F, Shao Z Y. The application of bacterial cellulose in biomedical materials. China Biotechnology, 2007,27(4):126-131.
|
[37] |
Maimoona Q, Dildar K, Naveed A, et al. Surfactant free, self-assembled nanomicelles-based transdermal hydrogel for safe and targeted delivery of methotrexate against rheumatoid arthritis. ACS Nano, 2020,14(4):4662-4681.
|
[38] |
夏加璇, 朱颖, 任宏伟, 等. 纳米制剂在类风湿性关节炎靶向治疗中的应用研究. 中国医药工业杂志, 2019,50(7):712-721.
|
|
Xia J X, Zhu Y, Ren H W, et al. Researches on nanomedicines in targeted therapy of rheumatoid arthritis. Chinese Journal of Pharmaceuticals, 2019,50(7):712-721.
|
[39] |
Wang Y L, Liu Z B, Li T, et al. Enhanced therapeutic effect of RGD-modified polymeric micelles loaded with low-dose methotrexate and nimesulide on rheumatoid arthritis. Theranostics, 2019,9(3):708-720.
pmid: 30809303
|
[40] |
Zhang N, Zhang S S, Xu C Y, et al. Decoy oligodeoxynucleotides, polysaccharides, and targeted peptide-functionalized gold nanorods for the combined treatment of rheumatoid arthritis. Advanced Healthcare Materials, 2018,7(23):e1800982.
|
[41] |
Wu Z Q, Xu K N, Min J K, et al. Folate-conjugated hydrophobicity modified glycol chitosan nanoparticles for targeted delivery of methotrexate in rheumatoid arthritis. Journal of Applied Biomaterials & Functional Materials, 2020,18:2280800020962629.
|
[42] |
Yang M D, Ding J X, Feng X R, et al. Scavenger receptor-mediated targeted treatment of collagen-induced arthritis by dextran sulfate-methotrexate prodrug. Theranostics, 2017,7(1):97-105.
|
[43] |
Trujillo-Nolasco R M, Morales-Avila E, Ocampo-García B E, et al. Preparation and in vitro evaluation of radiolabeled HA-PLGA nanoparticles as novel MTX delivery system for local treatment of rheumatoid arthritis. Materials Science and Engineering: C, 2019,103:109766.
|
[44] |
Juarranz Y, Gutiérrez-Ca?as I, Santiago B, et al. Differential expression of vasoactive intestinal peptide and its functional receptors in human osteoarthritic and rheumatoid synovial fibroblasts. Arthritis and Rheumatism, 2008,58(4):1086-1095.
|
[45] |
Koo O M Y, Rubinstein I, Onyüksel H. Actively targeted low-dose camptothecin as a safe, long-acting, disease-modifying nanomedicine for rheumatoid arthritis. Pharmaceutical Research, 2011,28(4):776-787.
doi: 10.1007/s11095-010-0330-4
pmid: 21132352
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|